Raffles Medical Group added on Monday Sep 26 that it added Mastocheck, a new breast cancer diagnostic tool, to its list of health screening services, adding that it is the first healthcare provider in Singapore.
Mastocheck is a blood-based test that can be used to supplement your routine mammogram to detect signs of breast cancer early in life.
Raffles Medical Group said in a press release that it is a convenient method that requires just a small amount of blood for diagnosis.
Mastocheck was approved for human use by the Korean Ministry of Food and Drug Safety in 2019.
Asian women tend to have denser breasts, where there is more gland tissue than fatty tissue. Breast tumours may be hard to detect through a routine mammogram.
Mastocheck can also be used to supplement the routine mammogram to increase the accuracy of detection of breast cancer early, said the medical group, which has 37 outlets across Singapore.